Octamer-binding protein 4 affects the cell biology and phenotypic transition of lung cancer cells involving β-catenin/E-cadherin complex degradation

Molecular Medicine Reports

Volumn 11, Issue 3, 2015, Pages 1851-1858

  Chen, Zhong Shu ^a,b   Ling, Dong Jin ^a,b   Zhang, Yang De ^a   Feng, Jian Xiong ^b   Zhang, Xue Yu ^b   Shi, Tian Sheng ^b  

^a Central South University   (China)

^b Jiang Xi Chest Hospital   (China)

Author keywords

Lung cancer; Octamer binding protein 4; catenin E cadherin degradation

Indexed keywords

BETA CATENIN; CYTOKERATIN; OCTAMER TRANSCRIPTION FACTOR 4; SHORT HAIRPIN RNA; UVOMORULIN; CADHERIN; PROTEIN BINDING; SMALL INTERFERING RNA;

A549 CELL LINE; ARTICLE; CANCER CELL; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; METASTASIS; NON SMALL CELL LUNG CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

BETA CATENIN; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN BINDING; PROTEOLYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84916618578     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2992     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Foroni C, Broggini M, Generali D and Damia G: Epithelial-mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact. Cancer Treat Rev 38: 689-697, 2012.
3. Drasin DJ, Robin TP and Ford HL: Breast cancer epithelial-to-mesenchymal transition: Examining the functional consequences of plasticity. Breast Cancer Res 13: 226, 2011.
4. Jechlinger M, Grünert S and Beug H: Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. J Mammary Gland Biol Neoplasia 7: 415-432, 2002.
5. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
6. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
7. Nichols J, Zevnik B, Anastassiadis K, et al: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391, 1998.
8. Hay DC, Sutherland L, Clark J and Burdon T: Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22: 225-235, 2004.
9. Boiani M and Schöler HR: Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6: 872-884, 2005.
10. Monk M and Holding C: Human embryonic genes re-expressed in cancer cells. Oncogene 20: 8085-8091, 2001.
11. Chen YC, Hsu HS, Chen YW, et al: Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3: e2637, 2008.
12. Kim RJ and Nam JS: OCT4 expression enhances features of cancer stem cells in a mouse model of breast cancer. Lab Anim Res 27: 147-152, 2011.
13. Zhang Y, Zhang X, Wang X, et al: Inhibition of LDH-A by lentivirus-mediated small interfering RNA suppresses intestinal-type gastric cancer tumorigenicity through the downregulation of Oct4. Cancer Lett 321: 45-54, 2012.
14. Guo Y, Liu S, Wang P, et al: Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59: 763-775, 2011.
15. Iida H, Suzuki M, Goitsuka R and Ueno H: Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncol 40: 71-79, 2012.
16. He W, Li K, Wang F, Qin YR and Fan QX: Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol 18: 712-719, 2012.
17. Schoenhals M, Kassambara A, De Vos J, et al: Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun 383: 157-162, 2009.
18. Zhang X, Han B, Huang J, Zheng B, Geng Q, Aziz F and Dong Q: Prognostic significance of OCT4 expression in adenocarcinoma of the lung. Jpn J Clin Oncol 40: 961-966, 2010.
19. Moreira AL, Gonen M, Rekhtman N and Downey RJ: Progenitor stem cell marker expression by pulmonary carcinomas. Mod Pathol 23: 889-895, 2010.
20. Li X, Wang J, Xu Z, et al: Expression of sox2 and oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci 13: 7663-7675, 2012.
21. Lee W, Jiang Z, Liu J, et al: The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477, 2010.
22. Brabletz T, Hlubek F, Spaderna S, et al: Invasion and metastasis in colorectal cancer: Epithelial-mesenchymal transition, mesen-chymal-epithelial transition, stemcells and beta-catenin. Cells Tissues Organs 179: 56-65, 2005.
23. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
24. Satelli A and Li S: Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046, 2011.
25. Mendez MG, Kojima S and Goldman RD: Vimentin induces changes incell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J 24: 1838-1851, 2010.
26. Zhang X, Liu G, Kang Y, et al: N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib resistant lung cancer cell lines. PLoS One 8: e57692, 2013.
27. König K, Meder L, Kröger C, et al: Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model. PLoS One 8: e57996, 2013.
28. Gumbiner B, Stevenson B and Grimaldi A: The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107: 1575-1587, 1988.
29. Provost E and Rimm DL: Controversies at the cytoplasmic face of the cadherin based adhesion complex. Curr Opin Cell Biol 11: 567-572, 1999.
30. Morin PJ, Sparks AB, Korinek V, et al: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta catenin or APC. Science 275: 1787-1790, 1997.
31. Korinek V, Barker N, Morin PJ, et al: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC?/ colon carcinoma. Science 275: 1784-1787, 1997.
32. Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004.
33. Bolós V, Peinado H, Pérez-Moreno MA, et al: The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116: 499-511, 2003.
34. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, et al: Autoregulation of E-cadherin expression by cadherin-cadherin interactions: The roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163: 847-857, 2003.
35. Sommers CL, Gelmann EP, Kemler R, et al: Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 54: 3544-3552, 1994.